December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Phase 3 Trial

Recent news which mentions Phase 3 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
Novartis's Kymriah Flunks In Late-Stage NHL Study
Tickers NVS
Tags Biotech NVS Briefs
From Benzinga
Investors React Positively To Data From Orphazyme's Neurodegenerative Disease Candidate
Tickers ORPH
Tags Briefs Phase 2 Trial Phase 3 Trial
From Benzinga
Why Did AstraZeneca's Alexion Stop Amyotrophic Lateral Sclerosis Trial?
Tickers AZN AZNCF
Tags AZN Biotech Benzinga
From Benzinga
See Why Coherus Stock Is Rising After Toripalimab Combination Trial In Lung Cancer
Tickers CHRS
Tags Movers CHRS Benzinga
From Benzinga
DMC Recommends Biophytis Continue Sarconeos COVID-19 Study
Tickers BPTS
Tags BPTS FDA Briefs
From Benzinga
Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
Tickers LLY
Tags Phase 3 Trial News Health Care
From Benzinga
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
Tickers VALN
Tags Biotech Benzinga News
From Benzinga
Sage Therapeutics Drops Two Zuranolone Depression Trials Deemed Unnecessary For Approval
Tickers SAGE
Tags Benzinga Biotech Health Care
From Benzinga
Marinus Files US Application For Ganaxolone For Genetic Epilepsy, Inks European Commercialization Pact With Orion
Tickers MRNS MRUS
Tags Long Ideas News epilepsy
From Benzinga
Outlook Therapeutics Stock Surges Positive ONS-5010 Data In Wet AMD Patients
Tickers OTLK RHHBY
Tags Benzinga Movers OTLK
From Benzinga
Galmed Stock Jumps As FDA Signs Off Use Of Aramchol Meglumine In Late Stage NASH Trial
Tickers GLMD
Tags General Market News Health Care
From Benzinga
MediWound's NexoBrid Shows Significant Beneficial Impact On Pediatric Burn Patients
Tickers MDWD
Tags Health Care Market News General
From Benzinga
Kadmon's REZUROCK Scores Quick FDA Win For Chronic Graft-Versus-Host Disease
Tickers KDMN
Tags Small Cap Phase 3 Trial KDMN
From Benzinga
Gilead's Lenacapavir Shows High Rates Of Virologic Suppression In Heavily Treated HIV Patients
Tickers GILD
Tags General HIV GILD
From Benzinga
GlaxoSmithKline's Anemia Candidate Shows Promise In Late-Stage Studies
Tickers AZN FGEN GSK
Tags GSK Small Cap Phase 3 Trial
From Benzinga
Alexion's Ultomiris Shows Compelling, Durable Efficacy In Rare Muscle Weakness Disorder
Tickers ALXN
Tags Health Care Market News General
From Benzinga
Theratechnologies In Search Of Potential Partner For Late-Stage NASH Study Of Tesamorelin, Reports Q2 Earnings
Tickers THTX
Tags News General NASH
From Benzinga
Equillium's Single Phase 3 Study In aGVHD To Support US Filing Of Itolizumab
Tickers EQ
Tags Integrated Telecommunication Services GVHD EQ
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.